skip navigation

AO 2004-23

U.S. Oncology

Summary

SSF's solicitation of subsidiaries' restricted classes.

Documents

Final opinion August 12, 2004
Date Name Document type
08/12/2004 AO 2004-23 Final Opinion
08/12/2004 Vote Votes
08/09/2004 Draft AO (OGC), Agenda Document 04-71 Draft Documents
08/06/2004 Supplement to Request AO Request, Supplemental Material, and Extensions of Time
07/09/2004 Supplement to Request AO Request, Supplemental Material, and Extensions of Time
06/28/2004 Supplement to Request AO Request, Supplemental Material, and Extensions of Time
06/10/2004 Request by U.S. Oncology, Inc. Good Government Fund AO Request, Supplemental Material, and Extensions of Time

Entities

Role Name Type
Requestor U.S. Oncology, Inc. Corporation (including LLCs electing corporate status)
Requestor U.S. Oncology, Inc. Good Government Committee Separate segregated fund
Counsel/Representative ShawPittman LLP Law Firm
Counsel/Representative Spulak, Thomas J. Individual
Counsel/Representative Ekery, Fred N. Individual
Counsel/Representative Kosova, Leonard A. Individual
Counsel/Representative Myron, Mark C. Individual